title: Indocyanine green mediated photothrombosis for the management of predominantly classic choroidal neovascularisation caused by age related macular degeneration.
abstract: OBJECTIVE
  To study the effectiveness of indocyanine green mediated photothrombosis in the management of predominantly classic subfoveal choroidal neovascularisation associated with age related macular degeneration.
  
  
  METHODS
  Prospective, non-comparative, interventional case series of nine patients with predominantly classic subfoveal choroidal neovascularisation secondary to age related macular degeneration who declined photocoagulation or verteporfin photodynamic therapy. Patients were submitted to one or more treatments with an intravenous injection of a small volume of high concentration indocyanine green solution followed by low irradiance, large spot 810 nm continuous laser application via a transpupillary approach. Main outcome measures were change in best corrected visual acuity and macular exudative manifestations.
  
  
  RESULTS
  After 12 months of follow up, the final best corrected visual acuity was the same (plus or minus two ETDRS lines) in five eyes (55%), improved more than two ETDRS lines in three eyes (33%), and worsened by more than two lines in the remaining eye. The improved vision was probably related to partial or complete restoration of the macular architecture as a result of fluid resolution, whereas the worsened vision was primarily the result of treatment failure in achieving substantial choroidal neovascular occlusion. There were no complications related to the procedure.
  
  
  CONCLUSIONS
  Indocyanine green mediated photothrombosis may be an effective alternative treatment for predominantly classic subfoveal choroidal neovascularisation caused by age related macular degeneration.
authors.affiliation: Department of Ophthalmology, Instituto da Visão-IPEPO, Federal University of São Paulo, School of Medicine, Brazil. mefarah@uol.com.br
authors.forename: M E
authors.initials: ME
authors.lastname: Farah
authors.forename: J A
authors.initials: JA
authors.lastname: Cardillo
authors.forename: A C
authors.initials: AC
authors.lastname: Luzardo
authors.forename: D
authors.initials: D
authors.lastname: Calucci
authors.forename: G A
authors.initials: GA
authors.lastname: Williams
authors.forename: R A
authors.initials: RA
authors.lastname: Costa
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007208:Indocyanine Green / Q000627:therapeutic use*; D008028:Light Coagulation; D008268:Macular Degeneration / Q000150:complications* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011446:Prospective Studies; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology
chemical_list: D017319:Photosensitizing Agents; D007208:Indocyanine Green